Systematic review and neural network analysis to define predictive variables in implantable motor cortex stimulation to treat chronic intractable pain

Implantable motor cortex stimulation (iMCS) to alleviate intractable pain was first described in the 1990s by Tsubokawa and colleagues.64,65 Since then, a total of 700 cases have been described worldwide and an unpredictable, often not long-lasting effect has been reported. Only a small number of studies investigated outcome prediction factors in iMCS treatment of intractable pain. Non-responders, on the other hand, have been far less studied over the years and therefore, little is known about their specific characteristics and underlying pain mechanisms.

from The Journal of Pain http://bit.ly/2SvtJF8
via IFTTT